MedPath

Effect of High Altitude Exposure, Acclimatization and Re-exposure on Nocturnal Breathing Pattern in Lowlanders

Not Applicable
Completed
Conditions
Effect of High Altitude
Registration Number
NCT02730143
Lead Sponsor
University of Zurich
Brief Summary

Prospective interventional trial in lowlanders evaluating the effect of acute exposure, acclimatization and re-exposure of high altitude on nocturnal breathing pattern.

Detailed Description

Respiratory polygraphies will be performed in Santiago de Chile, 520 m, over the course of 3 days. Participants will then travel by commercial airline (5 h flight) and by bus (3 h ride) to the ALMA base camp located at 2900 m near San Pedro de Atacama, northern Chile. Participants will stay there for the next 7 nights and respiratory polygraphies will be performed on night 1 and 6. They will be spend the days (6-8 h daily) at the telescope station at 5050 m while undergoing physiological testing. Daily transports from 2900 to 5050 m will be by car (1 h ride, one way). After the first 8 day altitude sojourn participants will return to the Santiago area (520 m) for a 6 day recovery period.

A second altitude sojourn with an identical schedule as the one described above and a final low altitude stay of 3 days will follow.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
21
Inclusion Criteria
  • born, raised and currently living <800m
  • No overnight stay at altitudes >1500 m 4 weeks before the study
Exclusion Criteria
  • Previous altitude intolerance to altitude <3000 m
  • Pregnancy
  • Health impairment, which requires regular treatment

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Mean nocturnal oxygen saturation measured by pulse oximetryfirst sojourn at 5050 m, night 1, 6; second sojourn at 5050 m, night 1, 6; low altitude sojourn at 520 m, night 1

Change in mean nocturnal oxygen saturation over the course of high altitude exposure during 2 sojourns at 5050 m compared to low altitude

Secondary Outcome Measures
NameTimeMethod
Acute mountain sickness measured by the Environmental Symptom questionnaire cerebral score (AMSc)first sojourn at 5050 m, day 2, 7; second sojourn at 5050 m, day 2,7; low altitude sojourn at 520 m, day 2

Incidence of acute mountain sickness (AMSc score \>= 0.7) over the course of high altitude exposure during 2 sojourns at 5050 m compared to low altitude

Oxygen desaturation index measured by respiratory polygraphyfirst sojourn at 5050 m, night 1, 6; second sojourn at 5050 m, night 1, 6; low altitude sojourn at 520 m, night 1

Change in oxygen desaturation index over the course of high altitude exposure during 2 sojourns at 5050 m compared to low altitude

Apnea-/hypopnea index measured by respiratory polygraphyfirst sojourn at 5050 m, night 1, 6; second sojourn at 5050 m, night 1, 6; low altitude sojourn at 520 m, night 1

Change in apnea-/hypopnea index over the course of high altitude exposure during 2 sojourns at 5050 m compared to low altitude

Trial Locations

Locations (1)

University of Zurich

🇨🇭

Zurich, Switzerland

University of Zurich
🇨🇭Zurich, Switzerland

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.